Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Midatech Pharma ADR (MTP)

Midatech Pharma ADR (MTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,178
  • Shares Outstanding, K 21,669
  • Annual Sales, $ 790 K
  • Annual Income, $ -7,510 K
  • 60-Month Beta 2.29
  • Price/Sales 0.28
  • Price/Cash Flow N/A
  • Price/Book 0.05
Trade MTP with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 04/25/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2851 unch
on 03/24/23
0.5698 -49.96%
on 03/01/23
-0.2548 (-47.19%)
since 02/24/23
3-Month
0.2851 unch
on 03/24/23
1.1300 -74.77%
on 12/30/22
-0.4350 (-60.41%)
since 12/23/22
52-Week
0.2851 unch
on 03/24/23
5.2500 -94.57%
on 04/05/22
-4.0154 (-93.37%)
since 03/24/22

Most Recent Stories

More News
Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma

Orphan Designation Granted by EMA to MTX110 Development for the Treatment of Glioma

MTP : 1.1404 (-18.52%)
Midatech Pharma PLC Announces Directorate Change

ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 20, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, is...

MTP : 1.1404 (-18.52%)
SAR : 25.74 (+9.14%)
Midatech Pharma PLC Announces Retirement of Chairman and Proposed New Chairman

ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, announces...

MTP : 1.1404 (-18.52%)
SAR : 25.74 (+9.14%)
MXC.LN : 22.000 (unch)
Midatech Pharma PLC - MTX110 Study to be Presented at ISPNO 2022

ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, is...

MTP : 1.1404 (-18.52%)
Midatech Pharma PLC Announces Fast Track Designation for MTX110 Development

Fast Track Designation Granted to MTX110 Development for the Treatment of Recurrent Glioblastoma

MTP : 1.1404 (-18.52%)
Midatech Pharma PLC Announces Posting of Annual Report & Notice of AGM

ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 24, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines,...

MTP : 1.1404 (-18.52%)
Midatech Pharma PLC Announces Results for the Year Ended 31 December 2021

ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 26, 2022 / Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces...

MTP : 1.1404 (-18.52%)
Midatech Pharma PLC Announces Receipt of NASDAQ Notice

ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 14, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines,...

MTP : 1.1404 (-18.52%)
Midpoint Announces Appointment of New CEO/CFO and Results of AGM

LONDON, UK / ACCESSWIRE / April 12, 2022 / Midpoint Holdings Ltd. (TSXV:MPT) (Frankfurt: 8MH1) ("Midpoint" or the "Company") is pleased to announce that all matters presented at its annual general and...

MTP : 1.1404 (-18.52%)
MPT.VN : 0.180 (unch)
Midatech Pharma PLC Announces R&D Collaboration with Janssen on Second Molecule

ABINGDON, UK / ACCESSWIRE / March 9, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is pleased...

MTP : 1.1404 (-18.52%)

Business Summary

Midatech Pharma Plc is focused on the discovery and development of pharmaceutical products of nanomedicine. The Company's product candidates, which are in clinical and pre-clinical development, are Transbuccal Insulin, glucagon-like-peptide, GLP-1/Insulin Combination, Q-Exenatide and Q-Octreotide. Midatech...

See More

Key Turning Points

3rd Resistance Point 0.3933
2nd Resistance Point 0.3716
1st Resistance Point 0.3284
Last Price 1.1404
1st Support Level 0.2635
2nd Support Level 0.2418
3rd Support Level 0.1986

See More

52-Week High 5.2500
Fibonacci 61.8% 3.3534
Fibonacci 50% 2.7675
Fibonacci 38.2% 2.1817
Last Price 1.1404
52-Week Low 0.2851

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar